Last-Hope cancer drug offered outside clinical trials

This program provides the investigational drug selinexor to patients with certain cancers who have run out of standard treatment options and don't qualify for ongoing clinical trials. It allows doctors to request the drug for eligible patients before it receives full regulatory approval or becomes commercially available in their country. The program is designed for people with specific cancers including multiple myeloma, lymphoma, sarcoma, and others.